Altogen Biosystems’ transfection reagents have been widely used in cancer research due to their high efficiency and low toxicity. These reagents are designed to deliver plasmid DNA, siRNA, miRNA, and other nucleic acids to cancer cells, enabling researchers to study the molecular mechanisms of cancer and develop new therapies.

Altogen Biosystems’ transfection reagents are available for a wide range of cancer cell lines, including breast cancer, prostate cancer, lung cancer, colon cancer, and others. The reagents are easy to use and have been optimized for maximum transfection efficiency.

In addition to its transfection reagents, Altogen Biosystems offers a range of cancer research services, including tumor xenograft studies, in vitro cell proliferation assays, and RNAi gene silencing.

Overall, Altogen Biosystems’ transfection reagents and cancer research services provide valuable tools for cancer researchers to study cancer biology and develop new cancer therapies.

Transfection Reagents | In Vivo Transfection Kits | Publications | Services